sj-docx-1-tan-10.1177_17562864231177196 – Supplemental material for Alemtuzumab following natalizumab is more effective in adult-onset than paediatric-onset multiple sclerosis

Abstract

Supplemental material, sj-docx-1-tan-10.1177_17562864231177196 for Alemtuzumab following natalizumab is more effective in adult-onset than paediatric-onset multiple sclerosis by Marco Puthenparampil, Marta Gaggiola, Alessandro Miscioscia, Valentina Annamaria Mauceri, Federica De Napoli, Giovanni Zanotelli, Mariagiulia Anglani, Margherita Nosadini, Stefano Sartori, Paola Perini, Francesca Rinaldi and Paolo Gallo in Therapeutic Advances in Neurological Disorders</p